Literature DB >> 26455498

Patient Perceptions of Telephone vs. In-Person BRCA1/BRCA2 Genetic Counseling.

Beth N Peshkin1,2, Scott Kelly3, Rachel H Nusbaum4, Morgan Similuk5, Tiffani A DeMarco6, Gillian W Hooker7, Heiddis B Valdimarsdottir8,9, Andrea D Forman10, Jessica Rispoli Joines11, Claire Davis12, Shelley R McCormick13, Wendy McKinnon14, Kristi D Graves15,16, Claudine Isaacs15,16, Judy Garber13, Marie Wood14, Lina Jandorf8, Marc D Schwartz15,16.   

Abstract

Telephone genetic counseling (TC) for hereditary breast/ovarian cancer risk has been associated with positive outcomes in high risk women. However, little is known about how patients perceive TC. As part of a randomized trial of TC versus usual care (UC; in-person genetic counseling), we compared high risk women's perceptions of: (1) overall satisfaction with genetic counseling; (2) convenience; (3) attentiveness during the session; (4) counselor effectiveness in providing support; and (5) counselor ability to recognize emotional responses during the session. Among the 554 participants (TC, N = 272; UC, N = 282), delivery mode was not associated with self-reported satisfaction. However, TC participants found counseling significantly more convenient than UC participants (OR = 4.78, 95 % CI = 3.32, 6.89) while also perceiving lower levels of support (OR = 0.56, 95 % CI = 0.40-0.80) and emotional recognition (OR = 0.53, 95 % CI = 0.37-0.76). In exploratory analyses, we found that non-Hispanic white participants reported higher counselor support in UC than in TC (69.4 % vs. 52.8 %; OR = 3.06, 95 % CI = 1.39-6.74), while minority women perceived less support in UC vs. TC (58.3 % vs. 38.7 %; OR = 0.80, 95 % CI = 0.39-1.65). We discuss potential research and practice implications of these findings which may further improve the effectiveness and utilization of TC.

Entities:  

Keywords:  BRCA1/BRCA2; Genetic counseling; Patient satisfaction; Telephone counseling

Mesh:

Year:  2015        PMID: 26455498      PMCID: PMC4829475          DOI: 10.1007/s10897-015-9897-6

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  48 in total

Review 1.  Adult measures of general health and health-related quality of life: Medical Outcomes Study Short Form 36-Item (SF-36) and Short Form 12-Item (SF-12) Health Surveys, Nottingham Health Profile (NHP), Sickness Impact Profile (SIP), Medical Outcomes Study Short Form 6D (SF-6D), Health Utilities Index Mark 3 (HUI3), Quality of Well-Being Scale (QWB), and Assessment of Quality of Life (AQoL).

Authors:  Lucy Busija; Eva Pausenberger; Terry P Haines; Sharon Haymes; Rachelle Buchbinder; Richard H Osborne
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-11       Impact factor: 4.794

2.  BRCA genetic counseling among at-risk Latinas in New York City: new beliefs shape new generation.

Authors:  Katarina M Sussner; Tiffany Edwards; Cristina Villagra; M Carina Rodriguez; Hayley S Thompson; Lina Jandorf; Heiddis B Valdimarsdottir
Journal:  J Genet Couns       Date:  2014-08-15       Impact factor: 2.537

3.  A global measure of perceived stress.

Authors:  S Cohen; T Kamarck; R Mermelstein
Journal:  J Health Soc Behav       Date:  1983-12

4.  Ethnic, racial and cultural identity and perceived benefits and barriers related to genetic testing for breast cancer among at-risk women of African descent in New York City.

Authors:  K M Sussner; T A Edwards; H S Thompson; L Jandorf; N O Kwate; A Forman; K Brown; N Kapil-Pair; D H Bovbjerg; M D Schwartz; H B Valdimarsdottir
Journal:  Public Health Genomics       Date:  2011-05-03       Impact factor: 2.000

5.  Patient satisfaction with cancer genetic counseling: a psychometric analysis of the Genetic Counseling Satisfaction Scale.

Authors:  Tiffani A DeMarco; Beth N Peshkin; Bryn D Mars; Kenneth P Tercyak
Journal:  J Genet Couns       Date:  2004-08       Impact factor: 2.537

6.  The role of non-verbal behaviour in racial disparities in health care: implications and solutions.

Authors:  Cynthia S Levine; Nalini Ambady
Journal:  Med Educ       Date:  2013-09       Impact factor: 6.251

7.  Evaluation of a clinical genetics service--a quality initiative.

Authors:  Alison M Elliott; Bernard N Chodirker; Patricia Bocangel; Aizeddin A Mhanni
Journal:  J Genet Couns       Date:  2014-03-21       Impact factor: 2.537

8.  Development of a tiered and binned genetic counseling model for informed consent in the era of multiplex testing for cancer susceptibility.

Authors:  Angela R Bradbury; Linda Patrick-Miller; Jessica Long; Jacquelyn Powers; Jill Stopfer; Andrea Forman; Christina Rybak; Kristin Mattie; Amanda Brandt; Rachelle Chambers; Wendy K Chung; Jane Churpek; Mary B Daly; Laura Digiovanni; Dana Farengo-Clark; Dominique Fetzer; Pamela Ganschow; Generosa Grana; Cassandra Gulden; Michael Hall; Lynne Kohler; Kara Maxwell; Shana Merrill; Susan Montgomery; Rebecca Mueller; Sarah Nielsen; Olufunmilayo Olopade; Kimberly Rainey; Christina Seelaus; Katherine L Nathanson; Susan M Domchek
Journal:  Genet Med       Date:  2014-10-09       Impact factor: 8.822

9.  Differences in BRCA counseling and testing practices based on ordering provider type.

Authors:  Deborah Cragun; Lucia Camperlengo; Emily Robinson; Meghan Caldwell; Jongphil Kim; Catherine Phelan; Alvaro N Monteiro; Susan T Vadaparampil; Thomas A Sellers; Tuya Pal
Journal:  Genet Med       Date:  2014-06-12       Impact factor: 8.822

10.  Development of a communication protocol for telephone disclosure of genetic test results for cancer predisposition.

Authors:  Linda J Patrick-Miller; Brian L Egleston; Dominique Fetzer; Andrea Forman; Lisa Bealin; Christina Rybak; Candace Peterson; Melanie Corbman; Julio Albarracin; Evelyn Stevens; Mary B Daly; Angela R Bradbury
Journal:  JMIR Res Protoc       Date:  2014-10-29
View more
  15 in total

1.  Evaluation of telephone genetic counselling to facilitate germline BRCA1/2 testing in women with high-grade serous ovarian cancer.

Authors:  Erin Tutty; Lara Petelin; Joanne McKinley; Mary-Anne Young; Bettina Meiser; Victoria M Rasmussen; Rowan Forbes Shepherd; Paul A James; Laura E Forrest
Journal:  Eur J Hum Genet       Date:  2019-04-08       Impact factor: 4.246

2.  Operationalizing the Reciprocal Engagement Model of Genetic Counseling Practice: a Framework for the Scalable Delivery of Genomic Counseling and Testing.

Authors:  Tara Schmidlen; Amy C Sturm; Shelly Hovick; Laura Scheinfeldt; J Scott Roberts; Lindsey Morr; Joseph McElroy; Amanda E Toland; Michael Christman; Julianne M O'Daniel; Erynn S Gordon; Barbara A Bernhardt; Kelly E Ormond; Kevin Sweet
Journal:  J Genet Couns       Date:  2018-02-19       Impact factor: 2.537

3.  Randomized Noninferiority Trial of Telephone vs In-Person Disclosure of Germline Cancer Genetic Test Results.

Authors:  Angela R Bradbury; Linda J Patrick-Miller; Brian L Egleston; Michael J Hall; Susan M Domchek; Mary B Daly; Pamela Ganschow; Generosa Grana; Olufunmilayo I Olopade; Dominique Fetzer; Amanda Brandt; Rachelle Chambers; Dana F Clark; Andrea Forman; Rikki Gaber; Cassandra Gulden; Janice Horte; Jessica M Long; Terra Lucas; Shreshtha Madaan; Kristin Mattie; Danielle McKenna; Susan Montgomery; Sarah Nielsen; Jacquelyn Powers; Kim Rainey; Christina Rybak; Michelle Savage; Christina Seelaus; Jessica Stoll; Jill E Stopfer; Xinxin Shirley Yao
Journal:  J Natl Cancer Inst       Date:  2018-09-01       Impact factor: 13.506

4.  Patient and genetic counselor perceptions of in-person versus telephone genetic counseling for hereditary breast/ovarian cancer.

Authors:  Aryana S Jacobs; Marc D Schwartz; Heiddis Valdimarsdottir; Rachel H Nusbaum; Gillian W Hooker; Tiffani A DeMarco; Jessica E Heinzmann; Wendy McKinnon; Shelley R McCormick; Claire Davis; Andrea D Forman; Alexandra Perez Lebensohn; Emily Dalton; Diana Moglia Tully; Kristi D Graves; Morgan Similuk; Scott Kelly; Beth N Peshkin
Journal:  Fam Cancer       Date:  2016-10       Impact factor: 2.375

5.  Psychological Impact of Learning CDKN2A Variant Status as a Genetic Research Result.

Authors:  Xuan Zhu; Emma R Leof; Kari G Rabe; Jennifer B McCormick; Gloria M Petersen; Carmen Radecki Breitkopf
Journal:  Public Health Genomics       Date:  2019-04-18       Impact factor: 2.000

6.  Randomized trial of proactive rapid genetic counseling versus usual care for newly diagnosed breast cancer patients.

Authors:  Marc D Schwartz; Beth N Peshkin; Claudine Isaacs; Shawna Willey; Heiddis B Valdimarsdottir; Rachel Nusbaum; Gillian Hooker; Suzanne O'Neill; Lina Jandorf; Scott P Kelly; Jessica Heinzmann; Aliza Zidell; Katia Khoury
Journal:  Breast Cancer Res Treat       Date:  2018-04-02       Impact factor: 4.872

7.  Development and Evaluation of a Telephone Communication Protocol for the Delivery of Personalized Melanoma Genomic Risk to the General Population.

Authors:  Georgina L Fenton; Amelia K Smit; Lucinda Freeman; Caro Badcock; Kate Dunlop; Phyllis N Butow; Judy Kirk; Anne E Cust
Journal:  J Genet Couns       Date:  2017-12-03       Impact factor: 2.537

8.  Perspectives on Genetic Testing and Return of Results from the First Cohort of Presymptomatically Tested Individuals At Risk of Huntington Disease.

Authors:  K M Stuttgen; J M Bollinger; R L Dvoskin; A McCague; B Shpritz; J Brandt; Debra J H Mathews
Journal:  J Genet Couns       Date:  2018-07-02       Impact factor: 2.537

9.  Development and early implementation of an Accessible, Relational, Inclusive and Actionable approach to genetic counseling: The ARIA model.

Authors:  Leslie Riddle; Laura M Amendola; Marian J Gilmore; Claudia Guerra; Barbara Biesecker; Tia L Kauffman; Katherine Anderson; Alan F Rope; Michael C Leo; Mikaella Caruncho; Gail P Jarvik; Benjamin Wilfond; Katrina A B Goddard; Galen Joseph
Journal:  Patient Educ Couns       Date:  2020-12-23

Review 10.  Telehealth Interventions Designed for Women: an Evidence Map.

Authors:  Karen M Goldstein; Leah L Zullig; Eric A Dedert; Amir Alishahi Tabriz; Timothy W Brearly; Giselle Raitz; Suchita Shah Sata; John D Whited; Hayden B Bosworth; Adelaide M Gordon; Avishek Nagi; John W Williams; Jennifer M Gierisch
Journal:  J Gen Intern Med       Date:  2018-10-03       Impact factor: 6.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.